- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
News
Article
Daily Derm Times: March 5, 2025
Author(s):
Key Takeaways
- A survey highlights significant diagnostic and treatment gaps in chronic hand eczema, indicating a need for improved understanding and therapies.
- Takeda is actively working to address clinical disparities in psoriasis research, focusing on increasing diversity in trial participation.
Catch up on dermatology news, highlights, and insights from the past 24 hours.
*Editor's Note: "Daily Derm Times" will pause beginning Thursday, March 6, and resume after the conclusion of the AAD Annual Meeting in Orlando, Florida. In the meantime, view our conference coverage here and be on the lookout for daily conference-oriented recaps.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
New Survey By LEO Pharma and Ipsos Highlights Diagnostic, Treatment Gaps in Chronic Hand Eczema
A new survey reveals widespread misunderstanding and lack of effective treatments in chronic hand eczema.
Celebrating Women’s History Month by Honoring Women in Dermatology: A Sit-Down Interview With WDS Legacy Awardee Dr Adelaide Hebert
Dematology Times' Editor in Chief interviews Adelaide Hebert, MD, who will be honored at the AAD 2025 Legacy Celebration for her impact on pediatric dermatology.
Takeda Targets Clinical Disparities in Psoriasis Research
Psoriasis trials are among the least diverse within dermatology, with participants predominantly being white men.
ICYMI: Quoin Files New Rapamycin Patent Applications for Rare Disease Treatment
The novel formulations will harness Quoin’s Invisicare technology to treat microcystic lymphatic malformations, venous malformations, and angiofibromas.
LaShell Robinson on Takeda’s Initiative to Improve Research Diversity
Robinson shared insights into how the company is working to fight clinical research disparities.
Experts Share Tips for Optimizing Topical vs Systemic Therapies for AD
Experts discussed personalized approaches to atopic dermatitis, from steroid-sparing topicals to biologics, highlighting rapid relief and long-term management strategies.
Polyherbal Lip Hydrant Healed Chapped and Rough Lips, Compared to Petroleum Gel
The novel formulation improved the appearance of dry and chapped lips after 28 days of use.
Q&A: Jonathan Bernstein, MD, FAAAAI, Discusses Advances in Chronic Spontaneous Urticaria Treatments and AAAAI Data
At AAAAI/WAO 2025, Bernstein explored new findings on rilzabrutinib and dupilumab in CSU, highlighting treatment gaps and future therapies.
